The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hui-Yuen, J. S.
Right arrow Articles by Yeung, R. S. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hui-Yuen, J. S.
Right arrow Articles by Yeung, R. S. M.
The Journal of Immunology, 2006, 176: 6294-6301.
Copyright © 2006 by The American Association of Immunologists

TNF-{alpha} Is Necessary for Induction of Coronary Artery Inflammation and Aneurysm Formation in an Animal Model of Kawasaki Disease1

Joyce S. Hui-Yuen*, Trang T. Duong* and Rae S. M. Yeung2,*,{dagger}

* Cancer Research Program and {dagger} Division of Rheumatology, Department of Paediatrics, The Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada

Kawasaki disease is the most common cause of multisystem vasculitis in childhood. The resultant coronary artery lesions make Kawasaki disease the leading cause of acquired heart disease in children in the developed world. TNF-{alpha} is a pleiotropic inflammatory cytokine elevated during the acute phase of Kawasaki disease. In this study, we report rapid production of TNF-{alpha} in the peripheral immune system after disease induction in a murine model of Kawasaki disease. This immune response becomes site directed, with migration to the coronary arteries dependent on TNF-{alpha}-mediated events. Production of TNF-{alpha} in the heart is coincident with the presence of inflammatory infiltrate at the coronary arteries, which persists during development of aneurysms. More importantly, inflammation and elastin breakdown in the coronary vessels are completely eliminated in the absence of TNF-{alpha} effector functions. Mice treated with the TNF-{alpha}-blocking agent etanercept, as well as TNFRI knockout mice, are resistant to development of both coronary arteritis and coronary aneurysm formation. Taken together, TNF-{alpha} is necessary for the development of coronary artery lesions in an animal model of Kawasaki disease. These findings have important implications for potential new therapeutic interventions in children with Kawasaki disease.




This article has been cited by other articles:


Home page
HeartHome page
L E Wood and R M R Tulloh
Kawasaki disease in children
Heart, May 1, 2009; 95(10): 787 - 792.
[Abstract] [Full Text] [PDF]


Home page
Ann Rheum DisHome page
C Plater-Zyberk, L A B Joosten, M M A Helsen, M I Koenders, P A Baeuerle, and W B van den Berg
Combined blockade of granulocyte-macrophage colony stimulating factor and interleukin 17 pathways potently suppresses chronic destructive arthritis in a tumour necrosis factor {alpha}-independent mouse model
Ann Rheum Dis, May 1, 2009; 68(5): 721 - 728.
[Abstract] [Full Text] [PDF]


Home page
Rheumatology (Oxford)Home page
C. C. Belizna, M. A. Hamidou, H. Levesque, L. Guillevin, and Y. Shoenfeld
Infection and vasculitis
Rheumatology, May 1, 2009; 48(5): 475 - 482.
[Abstract] [Full Text] [PDF]


Home page
Ann Rheum DisHome page
C Plater-Zyberk, L A B Joosten, M M A Helsen, J Hepp, P A Baeuerle, and W B van den Berg
GM-CSF neutralisation suppresses inflammation and protects cartilage in acute streptococcal cell wall arthritis of mice
Ann Rheum Dis, April 1, 2007; 66(4): 452 - 457.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2006 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2006 by The American Association of Immunologists, Inc. All rights reserved.